JIR
BTAL icon

James Investment Research’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

James Investment Research’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-334
Closed -$7K – 316
2023
Q1 		$7K Buy
+334
New +$6.72K ﹤0.01% 490

Other funds holding BTAL

TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
APA
Astoria Portfolio Advisors New York $470M AUM 21.04% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

James Investment Research's BTAL Position: Q2 2023 in Review

James Investment Research sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 334 shares — an estimated $7K sold.

James Investment Research first reported a position in BTAL in Q1 2023 and held it in 1 quarter. The position peaked at $7K in Q1 2023. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • James Investment Research reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 334 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $7K.
  • James Investment Research first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 1 quarter.
  • James Investment Research's AGF US Market Neutral Anti-Beta Fund position peaked at $7K in Q1 2023.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.